Bio Key International (BKYI) Equity Average (2016 - 2025)
Historic Equity Average for Bio Key International (BKYI) over the last 16 years, with Q3 2025 value amounting to $6.4 million.
- Bio Key International's Equity Average rose 149694.07% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 149694.07%. This contributed to the annual value of $2.4 million for FY2024, which is 2402.98% down from last year.
- Bio Key International's Equity Average amounted to $6.4 million in Q3 2025, which was up 149694.07% from $7.2 million recorded in Q2 2025.
- Bio Key International's Equity Average's 5-year high stood at $20.0 million during Q1 2021, with a 5-year trough of -$461625.0 in Q3 2024.
- In the last 5 years, Bio Key International's Equity Average had a median value of $6.4 million in 2025 and averaged $8.1 million.
- As far as peak fluctuations go, Bio Key International's Equity Average surged by 616476.55% in 2021, and later plummeted by 22155.35% in 2024.
- Bio Key International's Equity Average (Quarter) stood at $16.6 million in 2021, then tumbled by 50.22% to $8.3 million in 2022, then plummeted by 96.5% to $289008.0 in 2023, then surged by 575.6% to $2.0 million in 2024, then surged by 230.27% to $6.4 million in 2025.
- Its Equity Average stands at $6.4 million for Q3 2025, versus $7.2 million for Q2 2025 and $5.6 million for Q1 2025.